Protalix BioTherapeutics (PLX) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31% |
| Dec 31, 2025 | 0.14% |
| Sep 30, 2025 | 0.36% |
| Jun 30, 2025 | -0.20% |
| Mar 31, 2025 | -1.17% |
| Dec 31, 2024 | -2.73% |
| Sep 30, 2024 | -3.56% |
| Jun 30, 2024 | -4.87% |
| Mar 31, 2024 | -4.62% |
| Dec 31, 2023 | -4.89% |
| Sep 30, 2023 | -6.71% |
| Jun 30, 2023 | -7.75% |
| Mar 31, 2023 | -8.44% |
| Dec 31, 2022 | -9.92% |
| Sep 30, 2022 | -10.15% |
| Jun 30, 2022 | -10.18% |
| Mar 31, 2022 | -10.39% |
| Dec 31, 2021 | -10.63% |
| Sep 30, 2021 | -11.14% |
| Jun 30, 2021 | -12.04% |
| Mar 31, 2021 | -12.31% |
| Dec 31, 2020 | -13.04% |
| Dec 31, 2019 | -14.11% |
| Mar 31, 2019 | -14.29% |
| Dec 31, 2018 | -14.16% |
| Sep 30, 2018 | -14.30% |
| Jun 30, 2018 | -14.29% |
| Mar 31, 2018 | -14.18% |
| Dec 31, 2017 | -13.99% |
| Sep 30, 2017 | -13.68% |
| Jun 30, 2017 | -14.00% |
| Mar 31, 2017 | -13.51% |
| Dec 31, 2016 | -13.79% |
| Sep 30, 2016 | -13.16% |
| Jun 30, 2016 | -12.93% |
| Dec 31, 2015 | -11.00% |